Literature DB >> 27777942

In vivo reprogramming of hepatic myofibroblasts into hepatocytes attenuates liver fibrosis: back to the future?

Erica Novo1, Stefania Cannito1, Maurizio Parola1.   

Abstract

Entities:  

Year:  2016        PMID: 27777942      PMCID: PMC5067366          DOI: 10.21037/sci.2016.09.08

Source DB:  PubMed          Journal:  Stem Cell Investig        ISSN: 2306-9759


× No keyword cloud information.
  24 in total

1.  Differentiation and transplantation of human induced pluripotent stem cell-derived hepatocyte-like cells.

Authors:  Samira Asgari; Mohsen Moslem; Kamran Bagheri-Lankarani; Behshad Pournasr; Maryam Miryounesi; Hossein Baharvand
Journal:  Stem Cell Rev Rep       Date:  2013-08       Impact factor: 5.739

Review 2.  Trends in liver transplantation 2011.

Authors:  Patrizia Burra; Richard Freeman
Journal:  J Hepatol       Date:  2012       Impact factor: 25.083

3.  Direct conversion of mouse fibroblasts to hepatocyte-like cells by defined factors.

Authors:  Sayaka Sekiya; Atsushi Suzuki
Journal:  Nature       Date:  2011-06-29       Impact factor: 49.962

4.  Direct Reprogramming of Hepatic Myofibroblasts into Hepatocytes In Vivo Attenuates Liver Fibrosis.

Authors:  Guangqi Song; Martin Pacher; Asha Balakrishnan; Qinggong Yuan; Hsin-Chieh Tsay; Dakai Yang; Julia Reetz; Sabine Brandes; Zhen Dai; Brigitte M Pützer; Marcos J Araúzo-Bravo; Doris Steinemann; Tom Luedde; Robert F Schwabe; Michael P Manns; Hans R Schöler; Axel Schambach; Tobias Cantz; Michael Ott; Amar Deep Sharma
Journal:  Cell Stem Cell       Date:  2016-02-25       Impact factor: 24.633

Review 5.  Assessing the therapeutic potential of lab-made hepatocytes.

Authors:  Milad Rezvani; Andrew A Grimm; Holger Willenbring
Journal:  Hepatology       Date:  2016-05-26       Impact factor: 17.425

6.  Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

Authors:  Kazutoshi Takahashi; Shinya Yamanaka
Journal:  Cell       Date:  2006-08-10       Impact factor: 41.582

7.  Direct reprogramming of human fibroblasts to functional and expandable hepatocytes.

Authors:  Pengyu Huang; Ludi Zhang; Yimeng Gao; Zhiying He; Dan Yao; Zhitao Wu; Jin Cen; Xiaotao Chen; Changcheng Liu; Yiping Hu; Dongmei Lai; Zhenlei Hu; Li Chen; Ying Zhang; Xin Cheng; Xiaojun Ma; Guoyu Pan; Xin Wang; Lijian Hui
Journal:  Cell Stem Cell       Date:  2014-02-27       Impact factor: 24.633

8.  A novel murine model to deplete hepatic stellate cells uncovers their role in amplifying liver damage in mice.

Authors:  Juan E Puche; Youngmin A Lee; Jingjing Jiao; Costica Aloman; Maria I Fiel; Ursula Muñoz; Thomas Kraus; Tingfang Lee; Hal F Yee; Scott L Friedman
Journal:  Hepatology       Date:  2013-01       Impact factor: 17.425

Review 9.  Potential of human induced pluripotent stem cells in studies of liver disease.

Authors:  Fotios Sampaziotis; Charis-Patricia Segeritz; Ludovic Vallier
Journal:  Hepatology       Date:  2015-02-10       Impact factor: 17.425

10.  Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology.

Authors:  Christine C Hsu; Juliane S Troeger; Ingmar Mederacke; Peter Huebener; Xueru Mu; Dianne H Dapito; Jean-Philippe Pradere; Robert F Schwabe
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

View more
  1 in total

Review 1.  Reprogramming of Keratinocytes as Donor or Target Cells Holds Great Promise for Cell Therapy and Regenerative Medicine.

Authors:  Yuehou Zhang; Wenzhi Hu; Kui Ma; Cuiping Zhang; Xiaobing Fu
Journal:  Stem Cell Rev Rep       Date:  2019-10       Impact factor: 5.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.